Article info
PDFClinical science
Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study
- Correspondence to Dr Charles C Wykoff, Retina Consultants of Houston and Blanton Eye Institute, Houston Methodist Hospital and Weill Cornell Medical College, Houston, TX 77030, USA; ccwmd{at}houstonretina.com
Citation
Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study
Publication history
- Received June 27, 2017
- Revised August 1, 2017
- Accepted August 4, 2017
- First published August 16, 2017.
Online issue publication
April 19, 2018
Article Versions
- Previous version (19 April 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.